MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$153,785
Net loss
-$15,850,564
Total other income
(expense)
$135,995
Interest expense
$15,230
Other expense
$2,560
Loss from operations
-$15,986,559
Total operating
expenses
$15,986,559
Research and development
$9,771,940
General and
administrative
$6,214,619
Back
Back
Income Statement
source: myfinsight.com
CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (CNSP)